Joachim Feldkamp

Dr. Joachim Feldkamp

Klinikum Bielefeld, 33604 Bielefeld, Germany
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2020 in Experimental and Clinical Endocrinology & Diabetes
Verified
Journal Article
Closed access
PDF file
JFJoachim Feldkamp
Joachim Feldkamp
FGF. Grünwald
F. Grünwald
MLMarkus Luster
Markus Luster
KLKerstin Lorenz
Kerstin Lorenz
CVChristian Vorländer
Christian Vorländer
DFDagmar Führer-Sakel
Dagmar Führer-Sakel
Thyroid nodules and cysts are frequently diagnosed in Germany with a prevalence of about 20% in young adults reaching up to 70% in older adults. Surgery is the standard treatment of symptomatic nodules, nodules with suspicion of malignancy and thyroid cancer. Radioiodine treatment is applied for autonomously functioning nodules. During the last years new non-surgical and non-radioiodine techniques have been introduced to treat thyroid nodules. These techniques include ethanol/polidocanol treatment, radiofrequency, microwave, and laser ablation, and high frequency ultrasound ablation. A significant reduction in nodule size could be documented for these techniques in several studies, but long-term outcome data are missing. Until now, there is no general consensus regarding the appropriate indications for these methods. For this reason, the Thyroid Section (German Society for Endocrinology), the Thyroid Working Committee (German Society for Nuclear Medicine), and the German Association of Endocrine Surgeons (CAEK) for the German Society of General and Visceral Surgery (DGAV) reviewed the respective literature, discussed the pro and cons and developed a consensus statement and recommendation to help physicians and patients in their decision making. * Consensus statement and recommendation of the Thyroid Section (German Society for Endocrinology), the Thyroid Working Committee (German Society for Nuclear Medicine), and the German Association of Endocrine Surgeons (CAEK) for the German Society of General and Visceral Surgery (DGAV).

5 July 2018 in Hormone and Metabolic Research
Verified
Journal Article
Closed access
PDF file
JFJoachim Feldkamp
Joachim Feldkamp
KJKarsten Jungheim
Karsten Jungheim
MSMatthias Schott
Matthias Schott
BJBeatrix Jacobs
Beatrix Jacobs
MRMichael Roden
Michael Roden
Diabetic foot ulcers are a severe complication in patients with diabetes mellitus. Vitamin D is associated with impaired β-cell function and insulin resistance, and is necessary for wound healing and bone metabolism. We measured the serum concentrations of 25-hydroxyvitamin D3 in 104 patients (63 inpatients, 41 outpatients) with diabetic foot ulcers and compared them to 99 healthy humans (control) and 103 patients with diabetes mellitus type 2 without diabetic foot ulcers. Calcium, creatinine, and parathyroid hormone were measured in patients with diabetic foot ulcers. The data were analysed together with glycosylated hemoglobin A1c and the severity of diabetic foot lesions according to the Armstrong classification. Levels of 25-hydroxyvitamin D3 were lower (11.8±11.3 ng/ml, p<0.001) in patients with diabetic foot ulcers (mean age 70±12 years) than in the control group (27.2±12.2 ng/ml). No difference was found between in- and outpatients. Fifty-eight (55.8%) of patients with diabetic foot ulcers had a severe 25-hydroxyvitamin D3 deficiency with levels below 10 ng/ml. Only 12% of the patients had 25-hydroxyvitamin D3 levels above 20 ng/ml. Secondary hyperparathyroidism was found in 27.9% of patients and 11.5% of the patients were hypocalcemic. There was a negative correlation (r=–0.241) (p<00.1) between Armstrong classification and 25-hydroxyvitamin D3 status. In conclusion, patients with diabetic foot syndrome are at high risk of 25-hydroxyvitamin D3 deficiency. Thus, any patient with diabetic foot syndrome should undergo 25-hydroxyvitamin D3 measurement and supplementation, if values are found to be decreased.

25 November 2009 in DMW - Deutsche Medizinische Wochenschrift
Verified
Journal Article
Closed access
JFJoachim Feldkamp
Joachim Feldkamp
Die Autoimunthyreoiditis ist eine Autoimmunerkrankung mit familiär gehäuftem Auftreten und Bevorzugung des weiblichen Geschlechts. Im Erwachsenenalter ist die AIT die häufigste Ursache für eine Hypothyreose. Vermutlich spielt bei der Genese das zytotoxische T-Lymphozytenantigen 4 (CTL-4) eine wichtige Rolle. Die Diagnose wird durch eine Erhöhung der Antikörper gegen thyreoidale Peroxidase und gegen Thyreoglobulin und eine typische Echoarmut im Sonogrammm gestellt. Bei hypothyreoter Stoffwechsellage muss L-Thyroxin substitutiert werden. Die AIT kann als Sonderform postpartal auftreten sowie als Folge einer Zytokintherapie. Autoimmune thyroiditis (AIT) is an autoimmune disease with genetic background. Women are more likely to develop AIT. In adulthood, AIT is the most frequent cause for aquired hypothyroidism. Cytotoxic T-lyphocyte antigen (CTL-4) may play a role in the etiology of the disease. Diagnosis is made by determination of elevated antibodies against thyroid peroxidase and thyroglobulin, and a hypoechoic pattern in ultrasound. In case of hypothyroidism a substitutive therapy with levothyrooxine is necessary. AIT may occur as postpartum thyroiditis or as a special entity as consequence of therapy with zytokines.

27 May 2016 in Die Innere Medizin
Verified
Journal Article
Closed access
PDF file
JFJoachim Feldkamp
Joachim Feldkamp
MSM. Schott
M. Schott
MGM. Gogol
M. Gogol
MQM. Quinkler
M. Quinkler
MBM. Blüher
M. Blüher
MPMartin Reincke Prof
Martin Reincke Prof

1 September 2001 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
JFJoachim Feldkamp
Joachim Feldkamp

15 March 2022 in DMW - Deutsche Medizinische Wochenschrift
Verified
Journal Article
Closed access
PDF file
FRFranz Ruderich
Franz Ruderich
JFJoachim Feldkamp
Joachim Feldkamp
Definition und Epidemiologie Die subklinische Hypothyreose ist in der Regel eine Labordiagnose ohne signifikante Symptomatik und definiert durch ein erhöhtes TSH bei normalen Werten für freies T3 und freies T4. Bei Laborkontrollen nach 2–3 Monaten findet sich in 50 % der Fälle eine spontane Normalisierung. Klinische Bedeutung der subklinischen Hypothyreose Bei persistierend erhöhten TSH-Werten ist die subklinische Hypothyreose mit dem Nachweis von schilddrüsenspezifischen Antikörpern im Sinne einer Autoimmunthyreoiditis assoziiert. Im Alter finden sich physiologisch höhere TSH-Spiegel. Es ist deshalb davon auszugehen, dass die Diagnose einer subklinischen Hypothyreose bei älteren Menschen über 70 Jahre zu häufig gestellt und therapiert wird. Therapie der subklinischen Hypothyreose Studien konnten bisher keinen positiven Effekt einer Substitutionstherapie der subklinischen Hypothyreose zeigen, insbesondere nicht bei älteren Patienten. Andererseits besteht das nicht unerhebliche Risiko einer Übertherapie mit der Entwicklung einer subklinischen Hyperthyreose. Deren negative Folgen in Form von Vorhofflimmern und Osteoporose beeinträchtigen die Lebensqualität und -dauer. Bei der Indikationsstellung zur Substitutionstherapie einer subklinischen Hypothyreose sollte deshalb zurückhaltend vorgegangen werden. Subklinische Hypothyreose in der Schwangerschaft Eine Gruppe, bei der Diagnostik und Therapie besondere Sensibilität erfordern, sind schwangere Frauen. Hier müssen mit Mutter und Kind 2 Individuen behandelt werden. Dabei sind veränderliche Zielwerte und Dosierungen bezogen auf das Schwangerschaftsalter zu berücksichtigen. Subclinical hypothyroidism is usually a laboratory diagnosis without significant symptoms and is defined by an elevated thyroid-stimulating hormone (thyrotropin, TSH) with normal thyroid hormone levels. On laboratory checks after two to three months, spontaneous normalization is found in 50 % of all cases in the sense of a transient elevation. With persistently elevated TSH levels, subclinical hypothyroidism is associated with evidence of thyroid-specific antibodies in the sense of autoimmune thyroiditis. Physiologically higher TSH levels are found in old age. It can therefore be assumed that the diagnosis of subclinical hypothyroidism is made and treated too frequently in older people over 70 years of age. Studies have so far failed to show a positive effect of substitution therapy of subclinical hypothyroidism, especially in elderly patients. On the other hand, there is a not inconsiderable risk of overtreatment with the development of subclinical hyperthyroidism. Its negative consequences in the form of atrial fibrillation and osteoporosis impair the quality and duration of life. Therefore, the indication for substitution therapy of subclinical hypothyroidism should be made with caution. One group in which diagnosis and therapy require special sensitivity is pregnant women. Here, two individuals, mother and child, must be treated. Varying target values and dosages in relation to the gestational age must be taken into account. Publication Date: 15 March 2022 (online) © 2022. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany